search
Back to results

Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery (INCREASE)

Primary Purpose

Heart Valve Diseases

Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Enhanced Recovery After Surgery
Treatment as Usual
Sponsored by
Universitätsklinikum Hamburg-Eppendorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Valve Diseases focused on measuring randomized controlled trial, enhanced recovery after surgery, minimally invasive surgery, postanesthesia care unit, physiotherapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Indication for elective minimally invasive (open) aortic or mitral valve surgery
  • Patient's ability to understand the nature and extent of the individual's requirements for participation in the new care setting
  • Classification of the patient as "FIT" or "Pre-FRAIL" using the LUCAS functional index (frailty index) (Dapp et al. 2012)

Exclusion Criteria:

  • Limited life expectancy less than one year (e.g., advanced tumor disease)
  • Urgent or emergency interventions
  • Severe chronic obstructive pulmonary disease (GOLD III or IV)
  • Dialysis-dependant renal failure
  • Advanced liver cirrhosis (Child stages B + C)
  • Severe comorbidities or psychosocial reasons that militate against participation or do not allow for written informed consent (e. g., residual neurological impairment after prior stroke, major restrictions of mobility, neuropsychological disorders, depressive disorder, substance-related addictive disorders)
  • Lack of a social environment that can provide supportive patient care
  • Previous cardiac surgery (i.e., relative contraindication for minimally invasive technique)

Sites / Locations

  • Universitätsklinikum Augsburg
  • Universitätsklinikum Hamburg-EppendorfRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

ERAS protocol (intervention group)

Treatment as usual (control group)

Arm Description

The innovative care process in the intervention group is characterized by an interdisciplinary approach according to the previously established enhanced recovery after surgery protocol. This process aims at improving the clinical outcome after cardiac surgery, increasing patient satisfaction and quality of life, enabling early professional reentry and participation, and optimizing the cost-effectiveness of service provision. In addition, intersectoral barriers are being broken down in order to establish an interdisciplinary and cross-sectoral overall care process for patients with heart valve surgery as a new form of care in the future.

The control group undergoes standard heart valve surgery. In this case, no preoperative interventions take place, the patient is operated on the affected heart valve in a minimally invasive procedure without prehabilitation. After surgery, the patient is transfered to an intensive care unit (not a specialized postanesthesia care unit) depending on the individual condition and then transfered to the general ward. Patients receive medical, nursing, and physiotherapeutic care in accordance with current hospital standards.

Outcomes

Primary Outcome Measures

Hospitalization
number of hospitalized days due to cardiac reasons
Six Minute Walk Test
physical capacity expressed with the walking distance in meters

Secondary Outcome Measures

Goal Attainment Scale (GAS)
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
Goal Attainment Scale (GAS)
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
HeartQoL
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
HeartQoL
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
Costs
direct costs in € associated with the operative procedure and the initial hospitalization using diagnosis related groups as classification system, in which diagnoses and treatments are valued according to their necessary economical expenditure

Full Information

First Posted
June 18, 2021
Last Updated
August 21, 2022
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
BARMER, University Hospital Augsburg
search

1. Study Identification

Unique Protocol Identification Number
NCT04977362
Brief Title
Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery
Acronym
INCREASE
Official Title
Interdisciplinary and Cross-sectoral Perioperative Care Model in the Cardiac Surgery: Implementation in the Setting of Minimally-invasive Heart Valve Surgery (INCREASE)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
June 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
BARMER, University Hospital Augsburg

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Valvular heart diseases are among the most common cardiac pathologies in adult patients in Germany. Currently, the process of care before, during and after heart valve surgery does not follow a standardized and interdisciplinary optimal approach. An approach already established in other surgical disciplines is the Enhanced Recovery After Surgery (ERAS) protocol, which aims at optimizing the recovery process of patients. Within the INCREASE study, a care process inspired by the ERAS protocol will be established at the University Heart and Vascular Center (UHZ) of the University Medical Center Hamburg-Eppendorf (UKE) and the University Medical Center Augsburg (UKA). Executing the study at two facilities in different regions in Germany will help to demonstrate transferability of the process of care. The effectiveness of this process compared to the current treatment approach will be investigated in a randomized controlled trial. A total of 186 patients will be allocated by chance either to the intervention group (ERAS protocol) or the control group (treatment as usual). Patients in the intervention group will receive an optimized interdisciplinary care protocol including medical, nursing, physiotherapeutical and psychotherapeutical interventions. Measurements of effectiveness are the number of hospitalized days (due to cardiac causes) within one year and the physical condition of the patient as measured by the 6-minute walk test (6MWT) on the day of discharge.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Valve Diseases
Keywords
randomized controlled trial, enhanced recovery after surgery, minimally invasive surgery, postanesthesia care unit, physiotherapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial
Masking
Investigator
Masking Description
All scientists and statisticans involved in the analysis of the study will be blinded to the allocation of participants and will receive only pseudomized data from the study coordinator, who organises data collection.
Allocation
Randomized
Enrollment
186 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ERAS protocol (intervention group)
Arm Type
Experimental
Arm Description
The innovative care process in the intervention group is characterized by an interdisciplinary approach according to the previously established enhanced recovery after surgery protocol. This process aims at improving the clinical outcome after cardiac surgery, increasing patient satisfaction and quality of life, enabling early professional reentry and participation, and optimizing the cost-effectiveness of service provision. In addition, intersectoral barriers are being broken down in order to establish an interdisciplinary and cross-sectoral overall care process for patients with heart valve surgery as a new form of care in the future.
Arm Title
Treatment as usual (control group)
Arm Type
Active Comparator
Arm Description
The control group undergoes standard heart valve surgery. In this case, no preoperative interventions take place, the patient is operated on the affected heart valve in a minimally invasive procedure without prehabilitation. After surgery, the patient is transfered to an intensive care unit (not a specialized postanesthesia care unit) depending on the individual condition and then transfered to the general ward. Patients receive medical, nursing, and physiotherapeutic care in accordance with current hospital standards.
Intervention Type
Other
Intervention Name(s)
Enhanced Recovery After Surgery
Other Intervention Name(s)
fast track, rapid recovery, ERAS
Intervention Description
Enhanced recovery after surgery is a multimodal, transdisciplinary care approach for patients undergoing surgical procedures. It is implemented in various surgical specialties, among others in cardiac surgery. The care approach aims at promotion of recovery of the patients throughout their perioperative process, reduction of complications, and early return to normal activities.
Intervention Type
Other
Intervention Name(s)
Treatment as Usual
Intervention Description
treatment as usual according to standard care in heart valve surgery
Primary Outcome Measure Information:
Title
Hospitalization
Description
number of hospitalized days due to cardiac reasons
Time Frame
twelve months
Title
Six Minute Walk Test
Description
physical capacity expressed with the walking distance in meters
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Secondary Outcome Measure Information:
Title
Goal Attainment Scale (GAS)
Description
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
Time Frame
three months
Title
Goal Attainment Scale (GAS)
Description
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
Time Frame
twelve months
Title
HeartQoL
Description
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
Time Frame
three months
Title
HeartQoL
Description
health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life
Time Frame
twelve months
Title
Costs
Description
direct costs in € associated with the operative procedure and the initial hospitalization using diagnosis related groups as classification system, in which diagnoses and treatments are valued according to their necessary economical expenditure
Time Frame
up to 10 days
Other Pre-specified Outcome Measures:
Title
European Health Literacy Questionnaire (HLS-EU-Q16)
Description
health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
European Health Literacy Questionnaire (HLS-EU-Q16)
Description
health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy
Time Frame
twelve months
Title
Brief Illnness Perception Questionnaire (BIPQ)
Description
individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Brief Illnness Perception Questionnaire (BIPQ)
Description
individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception
Time Frame
twelve months
Title
Treatment Expectation Questionnaire (TEX-Q)
Description
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Treatment Expectation Questionnaire (TEX-Q)
Description
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
Time Frame
three months
Title
Treatment Expectation Questionnaire (TEX-Q)
Description
treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment
Time Frame
twelve months
Title
Patient Health Questionnaire-9 (PHQ-9)
Description
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Patient Health Questionnaire-9 (PHQ-9)
Description
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
Time Frame
three months
Title
Patient Health Questionnaire-9 (PHQ-9)
Description
depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms
Time Frame
twelve months
Title
Generalized Anxiety Disorder-2 (GAD-2)
Description
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Generalized Anxiety Disorder-2 (GAD-2)
Description
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
Time Frame
three months
Title
Generalized Anxiety Disorder-2 (GAD-2)
Description
anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms
Time Frame
twelve months
Title
Cardiac Anxiety Questionnaire (CAQ)
Description
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Cardiac Anxiety Questionnaire (CAQ)
Description
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
Time Frame
three months
Title
Cardiac Anxiety Questionnaire (CAQ)
Description
cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety
Time Frame
twelve months
Title
Life Orientation Test - revised (LOT-R)
Description
optimism; 10 items, min 0, max 24, higher scores indicating higher optimism
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Somatic Symptom Scale-8 (SSS-8)
Description
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Somatic Symptom Scale-8 (SSS-8)
Description
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
Time Frame
three months
Title
Somatic Symptom Scale-8 (SSS-8)
Description
somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden
Time Frame
twelve months
Title
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Description
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Description
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
Time Frame
three months
Title
Somatic Symptom Disorder - B Criteria Scale (SSD-12)
Description
coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms
Time Frame
twelve months
Title
International Physical Activity Questionnaire Short Form (IPAQ)
Description
level of physical activity
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
International Physical Activity Questionnaire Short Form (IPAQ)
Description
level of physical activity
Time Frame
twelve months
Title
Hand Dynamometer
Description
hand grip strength
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Hand Dynamometer
Description
hand grip strength
Time Frame
twelve months
Title
1 Minute Sit to Stand Test (1STS)
Description
physical capacity expressed with the number of repetitions
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
1 Minute Sit to Stand Test (1STS)
Description
physical capacity expressed with the number of repetitions
Time Frame
twelve months
Title
Timed Up and Go (TUG)
Description
physical capacity expressed with the duration in seconds
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Timed Up and Go (TUG)
Description
physical capacity expressed with the duration in seconds
Time Frame
twelve months
Title
Six Minute Walk Test
Description
physical capacity expressed with the walking distance in meters
Time Frame
twelve months
Title
Goal Attainment Scale (GAS)
Description
level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
Readiness for Hospital Discharge Scale (RHDS)
Description
readiness for hospital discharge; 9 items, min 0, max 36, higher scores indicating higher readniss to discharge
Time Frame
day of discharge (approx. 5 - 10 days after operation)
Title
5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L)
Description
health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition)
Time Frame
three months
Title
5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L)
Description
health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition)
Time Frame
twelve months
Title
Questionnaire for Health-Related Resource Use in an Elderly Population (FIMA)
Description
use of health care services; 11 items collecting numbers of health care services and days of usage, min 0, higher scores indicating higher usage of services
Time Frame
twelve months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Indication for elective minimally invasive (open) aortic or mitral valve surgery Patient's ability to understand the nature and extent of the individual's requirements for participation in the new care setting Classification of the patient as "FIT" or "Pre-FRAIL" using the LUCAS functional index (frailty index) (Dapp et al. 2012) Exclusion Criteria: Limited life expectancy less than one year (e.g., advanced tumor disease) Urgent or emergency interventions Severe chronic obstructive pulmonary disease (GOLD III or IV) Dialysis-dependant renal failure Advanced liver cirrhosis (Child stages B + C) Severe comorbidities or psychosocial reasons that militate against participation or do not allow for written informed consent (e. g., residual neurological impairment after prior stroke, major restrictions of mobility, neuropsychological disorders, depressive disorder, substance-related addictive disorders) Lack of a social environment that can provide supportive patient care Previous cardiac surgery (i.e., relative contraindication for minimally invasive technique)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Evaldas Girdauskas, Prof.
Phone
+49 821 400 2671
Email
herzchirurgie@uk-augsburg.de
First Name & Middle Initial & Last Name or Official Title & Degree
Jelena Bagnjuk, MSc
Phone
+ 49 40 7410 58685
Email
j.bagnjuk@uke.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Evaldas Girdauskas, Prof.
Organizational Affiliation
Universitätsklinikum Hamburg-Eppendorf
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitätsklinikum Augsburg
City
Augsburg
State/Province
Bavaria
ZIP/Postal Code
86156
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Evaldas Girdauskas, Prof.
Phone
+49 821 400 2671
Email
herzchirurgie@uk-augsburg.de
Facility Name
Universitätsklinikum Hamburg-Eppendorf
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jelena Bagnjuk, MSc
Phone
+ 49 40 7410 58685
Email
j.bagnjuk@uke.de

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32271849
Citation
Kubitz JC, Schulte-Uentrop L, Zoellner C, Lemke M, Messner-Schmitt A, Kalbacher D, Sill B, Reichenspurner H, Koell B, Girdauskas E. Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery. PLoS One. 2020 Apr 9;15(4):e0231378. doi: 10.1371/journal.pone.0231378. eCollection 2020.
Results Reference
background
PubMed Identifier
33743698
Citation
Petersen J, Kloth B, Konertz J, Kubitz J, Schulte-Uentrop L, Ketels G, Reichenspurner H, Girdauskas E. Economic impact of enhanced recovery after surgery protocol in minimally invasive cardiac surgery. BMC Health Serv Res. 2021 Mar 20;21(1):254. doi: 10.1186/s12913-021-06218-5.
Results Reference
background
PubMed Identifier
35739541
Citation
Klotz SGR, Ketels G, Behrendt CA, Konig HH, Kohlmann S, Lowe B, Petersen J, Stock S, Vettorazzi E, Zapf A, Zastrow I, Zollner C, Reichenspurner H, Girdauskas E. Interdisciplinary and cross-sectoral perioperative care model in cardiac surgery: implementation in the setting of minimally invasive heart valve surgery (INCREASE)-study protocol for a randomized controlled trial. Trials. 2022 Jun 23;23(1):528. doi: 10.1186/s13063-022-06455-x. Erratum In: Trials. 2022 Oct 5;23(1):853.
Results Reference
background
Links:
URL
https://innovationsfonds.g-ba.de/projekte/neue-versorgungsformen/increase-interdisziplinaere-und-sektorenuebergreifende-versorgung-in-der-herzchirurgie-am-beispiel-von-minimal-invasiven-herzklappeneingriffen.377
Description
summary of the project on the sponsor's website

Learn more about this trial

Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery

We'll reach out to this number within 24 hrs